European stocks are moving higher on Thursday as investors are optimistic about the results of a recent study on the micron that showed that the risk of hospitalization is lower compared to Delta.
In particular, research from Imperial College London shows that the risk of needing hospitalization for patients infected with the Omicron variant of Covid-19 is 40-45% lower than for those infected with Delta. “In general, we find evidence that the risk of hospitalization with Omicron is reduced, compared to Delta, in all cases identified during the study period,” the researchers note.
Another study from South Africa – where the new strain was first identified – also shows a reduced risk of hospitalization and serious illness. The study found that people diagnosed with micronutrients in South Africa between October 1 and November 3 were 80% less likely to be hospitalized than other strains during the same period.
The news that Pfizer’s pill against Covid-19 has given the green light for emergency use in the United States and the announcement by AstraZeneca that the booster dose of its vaccine significantly boosts the levels of anti-micron antibodies also gave a boost to investment psychology.
Analysts warn, however, that it is too early to know for sure whether Omicron is more or less dangerous, despite the encouraging data that has been announced so far. The rapid spread of the new mutation has forced many European governments to implement severely restrictive measures, again affecting economic activity.
On the dashboard, the STOXX 600 gains 0.4% to 480.26 points.
The German DAX is up 0.5% at 15,669.17 points, the French CAC 40 is up 0.3% at 7,071.30 points, while the British FTSE 100 is up 0.2% at 7,356.81 points.
In the region, the Italian FTSE MIB gained 0.3%, while the Spanish IBEX 35 strengthened by 0.9% after the data showed that the Spanish economy grew faster in the third quarter than expected, by 2.6% , compared to the initial announcement for 2% growth.
.
I am Sophia william, author of World Stock Market. I have a degree in journalism from the University of Missouri and I have worked as a reporter for several news websites. I have a passion for writing and informing people about the latest news and events happening in the world. I strive to be accurate and unbiased in my reporting, and I hope to provide readers with valuable information that they can use to make informed decisions.
